Literature DB >> 23656342

Emerging artemisinin resistance in the border areas of Thailand.

Kesara Na-Bangchang1, Juntra Karbwang.   

Abstract

Emergence of artemisinin resistance has been confirmed in Cambodia and the border areas of Thailand, the well-known hotspots of multidrug resistance Plasmodium falciparum. It appears to be spreading to the western border of Thailand along the Thai-Myanmar border, and will probably spread to other endemic areas of the world in the near future. This raises a serious concern on the long-term efficacy of artemisinin-based combination therapies, as these combination therapies currently constitute the last effective and most tolerable treatment for multidrug-resistant Plasmodium falciparum. Attempts have been made by a diverse array of stakeholders to prevent the emergence of new foci of artemisinin resistance, as well as to limit the spread of resistance to the original foci. The success in achieving this goal depends on effective integration of containment and surveillance programs with other malaria control measures, with support from both basic and operational research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23656342     DOI: 10.1586/ecp.13.17

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  16 in total

1.  Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.

Authors:  Xiaohong Peng; Gladys J Keitany; Marissa Vignali; Lin Chen; Claire Gibson; Kimberly Choi; Fusheng Huang; Ruobing Wang
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

2.  Carboxymefloquine, the major metabolite of the antimalarial drug mefloquine, induces drug-metabolizing enzyme and transporter expression by activation of pregnane X receptor.

Authors:  Rita Piedade; Stefanie Traub; Andreas Bitter; Andreas K Nüssler; José P Gil; Matthias Schwab; Oliver Burk
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

3.  Multiple Phenotypic and Genotypic Artemisinin Sensitivity Evaluation of Malian Plasmodium falciparum Isolates.

Authors:  Karamoko Niaré; Lucie Paloque; Sandie Ménard; Pety Tor; Arba P Ramadani; Jean-Michel Augereau; Antoine Dara; Antoine Berry; Françoise Benoit-Vical; Ogobara K Doumbo
Journal:  Am J Trop Med Hyg       Date:  2018-02-08       Impact factor: 2.345

4.  Polymorphisms in Plasmodium falciparum Kelch 13 and P. vivax Kelch 12 Genes in Parasites Collected from Three South Pacific Countries Prior to Extensive Exposure to Artemisinin Combination Therapies.

Authors:  Karryn Gresty; Karen Anderson; Cielo Pasay; Norman C Waters; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

5.  Preliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria.

Authors:  Papichaya Phompradit; Poonuch Muhamad; Anurak Cheoymang; Kesara Na-Bangchang
Journal:  Am J Trop Med Hyg       Date:  2014-06-02       Impact factor: 2.345

6.  Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.

Authors:  Katherine Kay; Eva Maria Hodel; Ian M Hastings
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

7.  In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013.

Authors:  Hui Liu; Heng-lin Yang; Lin-hua Tang; Xing-liang Li; Fang Huang; Jia-zhi Wang; Chun-fu Li; Heng-ye Wang; Ren-hua Nie; Xiang-rui Guo; Ying-xue Lin; Mei Li; Jian Wang; Jian-wei Xu
Journal:  Malar J       Date:  2015-02-05       Impact factor: 2.979

8.  Predicting functional and regulatory divergence of a drug resistance transporter gene in the human malaria parasite.

Authors:  Geoffrey H Siwo; Asako Tan; Katrina A Button-Simons; Upeka Samarakoon; Lisa A Checkley; Richard S Pinapati; Michael T Ferdig
Journal:  BMC Genomics       Date:  2015-02-22       Impact factor: 3.969

9.  Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border.

Authors:  Papichaya Phompradit; Poonuch Muhamad; Raewadee Wisedpanichkij; Wanna Chaijaroenkul; Kesara Na-Bangchang
Journal:  Malar J       Date:  2014-01-15       Impact factor: 2.979

10.  A population genetic model for the initial spread of partially resistant malaria parasites under anti-malarial combination therapy and weak intrahost competition.

Authors:  Yuseob Kim; Ananias A Escalante; Kristan A Schneider
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.